Showing results (91-100 of 115) with videos related to
Sort By:
Pageof 12
World Journal of Urology|May 31, 2018
Advanced non-contrasted computed tomography post-processing by CT-Calculometry (CT-CM) outperforms established predictors for the outcome of shock wave lithotripsyJ Langenauer, P Betschart, L Hechelhammer, et al.Cancer|February 1, 1993
Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancerT A Stamey, F S Freiha, J E McNeal, et al.The Biochemical Journal|August 15, 1997
Involvement of proteasomal subunits zeta and iota in RNA degradationF Petit, A S Jarrousse, B Dahlmann, et al.Cancer|May 1, 1997
A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Swiss Group for Clinical Cancer Research, Berne, SwitzerlandH P Schmid, R Maibach, J Bernhard, et al.Aktuelle Urologie|October 2, 2004
[Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens]L Prikler, E Scandella, Y Men, et al.Journal of Molecular Biology|February 20, 1986
Prosomes. Ubiquity and inter-species structural variationC Martins de Sa, M F Grossi de Sa, O Akhayat, et al.Presse Medicale (Paris, France : 1983)|February 24, 1996
[Detection of prostatic cancer in symptomatic patients with serum levels of prostate-specific antigen between 4 and 10 ng/ml]V Ravery, H P Schmid, T Billebaud, et al.Prostate Cancer and Prostatic Diseases|September 15, 2005
Hypertriglyceridemia as a possible risk factor for prostate cancerL Wuermli, M Joerger, S Henz, et al.Molecular Biology Reports|January 1, 1995
Relationships between proteasomes and RNAH P Schmid, M N Pouch, F Petit, et al.Pageof 12